BTBD14A anticorps (C-Term)
Aperçu rapide pour BTBD14A anticorps (C-Term) (ABIN6739477)
Antigène
Voir toutes BTBD14A AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- Human NACC2 / BTBD14A
-
Homologie
- Percent identity by BLAST analysis:
-
Purification
- Immunoaffinity purified
-
Immunogène
-
Synthetic peptide from C-Terminus of human LOC653428.
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Indications d'application
-
Approved: WB
Usage: ELISA titer using peptide based assay: 1:62500. Western Blot: Suggested dilution at 0.5 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1:50000 - 100000 as second antibody. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Distilled Water.
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Conseil sur la manipulation
- Avoid repeat freeze-thaw cycles.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- BTBD14A (BTB (POZ) Domain Containing 14A (BTBD14A))
-
Autre désignation
- NACC2 / BTBD14A
-
Sujet
-
Name/Gene ID: NACC2
Synonyms: NACC2, BEN domain containing 9, BEND9, BTBD14A, NAC-2, BTBD14, BTBD31, NAC2 -
ID gène
- 138151
-
UniProt
- Q96BF6
-
Pathways
- Positive Regulation of Response to DNA Damage Stimulus
Antigène
-